2015
DOI: 10.1016/j.ijpharm.2015.09.054
|View full text |Cite
|
Sign up to set email alerts
|

Tadalafil-loaded nanostructured lipid carriers using permeation enhancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 54 publications
(22 citation statements)
references
References 47 publications
1
21
0
Order By: Relevance
“…In another study, the PS of SLNs decreased considerably from 426 to 311 nm and PDI reduced from 0.38 to 0.24 when soya lecithin concentration was increased from 20 to 50% [ 160 ]. Similar results have been reported for oleic acid [ 42 , 181 ], MCT [ 4 ], and phosphatidylcholine [ 169 ]. The smaller PS and PDI of NLCs produced at higher liquid lipid levels are attributed to reductions in lipid blend viscosity [ 4 , 42 , 182 ].…”
Section: Effect Of Formulation Parameters On Slns and Nlcs Producesupporting
confidence: 88%
“…In another study, the PS of SLNs decreased considerably from 426 to 311 nm and PDI reduced from 0.38 to 0.24 when soya lecithin concentration was increased from 20 to 50% [ 160 ]. Similar results have been reported for oleic acid [ 42 , 181 ], MCT [ 4 ], and phosphatidylcholine [ 169 ]. The smaller PS and PDI of NLCs produced at higher liquid lipid levels are attributed to reductions in lipid blend viscosity [ 4 , 42 , 182 ].…”
Section: Effect Of Formulation Parameters On Slns and Nlcs Producesupporting
confidence: 88%
“…The partition coefficient and solubility of PR in the lipid matrix are major factors determining encapsulation efficiency (EE) and loading capacity (LC) in the NLCs [ 11 ]. Therefore, we investigated the partition coefficient of PR in solid lipids and the solubility of PR in liquid lipids to determine conditions for loading the maximum amount of PR into the NLC.…”
Section: Resultsmentioning
confidence: 99%
“…However, suffering from poor aqueous solubility, tadalafil is a BCS class II drug. Numerous approaches for enhancing its dissolution rate were reported including the use of solid dispersions 29 , complexation with cyclodextrins 30 , inclusion in microporous silicas 31 , formulation of nanosuspensions 32 , use of self-nanoemulsifying drug delivery systems (SNEDDS) 33 , and nanostructured lipid carriers (NLCs) 34 . However, to the best of our knowledge, liquisolid technique has never been utilized to promote the dissolution of tadalafil in the reported literatures.…”
Section: Introductionmentioning
confidence: 99%